trending Market Intelligence /marketintelligence/en/news-insights/trending/Ng5CblpgNCJlbGtr2a_6Ag2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

GSK exec joins Novelion Therapeutics as EVP/head of R&D

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


GSK exec joins Novelion Therapeutics as EVP/head of R&D

Murray Stewart will become Novelion Therapeutics Inc.'s executive vice president and head of research and development Nov. 27.

Stewart is joining Novelion Therapeutics from GlaxoSmithKline plc, where he serves as the chief medical officer.